US Adds Three Chinese Genomics Companies to Forced Labor Import Restrictions
The restrictions took effect Oct. 29, limiting US imports of goods produced by BGI Genomics, MGI Tech, and BGI Group over alleged ties to forced labor in China.
The restrictions took effect Oct. 29, limiting US imports of goods produced by BGI Genomics, MGI Tech, and BGI Group over alleged ties to forced labor in China.
Beckman Coulter Diagnostics has appointed Catherine Jennings, former president of vascular therapies at Boston Scientific, as president. Jennings will lead global strategy and operations for the Danaher-owned clinical diagnostics company.
CMS has released preliminary 2027 CLFS rates, with data showing weighted median payment cuts for over 1,100 test codes; annual reductions are capped at 15% from 2027 to 2029 under current policy.
The College of American Pathologists has updated 14 Cancer Protocols, mandating the Breast Phyllodes Tumor protocol for accreditation and revising breast biomarker and GIST molecular testing criteria, according to CAP.
A global survey of 231 labs in 41 countries, published by IOF and IFCC, reveals significant inconsistencies in bone biomarker testing methods, reference intervals, and quality assessments, highlighting a need for greater harmonization.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
Baylor Genetics has been named lead sequencing provider for Florida’s five-year Sunshine Genetics Pilot, which will use whole-genome sequencing to screen newborns for nearly 900 genetic conditions statewide.
Urinalysis comparison guide featuring testing capabilities, technology, throughput, connectivity, sample capacity, and key specifications from leading systems.